CIA
ONC

Cape Investment Advisory’s BeOne Medicines Ltd ONC Stock Holding History

Cape Investment Advisory’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.99K Buy
+21
New +$6.19K ﹤0.01% 985
2026
Q1 		– Sell
-18
Closed -$5.47K – 1290
2025
Q4 		$5.47K Hold
18
– – ﹤0.01% 884
2025
Q3 		$6.13K Buy
18
+8
+80% +$2.43K 0.01% 483
2025
Q2 		$2.42K Buy
+10
New +$2.45K ﹤0.01% 910

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Cape Investment Advisory's ONC Position: Q2 2026 in Review

Cape Investment Advisory opened a new position in BeOne Medicines Ltd (ONC) in Q2 2026: 21 shares worth $5.99K. The stake represents ﹤0.01% of the portfolio and ranks #985 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in ONC as recently as Q4 2025.

Cape Investment Advisory first reported a position in ONC in Q2 2025 and has held it in 4 quarters since. The position peaked at $6.13K in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Cape Investment Advisory held 21 shares of BeOne Medicines Ltd worth $5.99K as of Q2 2026.
  • BeOne Medicines Ltd was a new Cape Investment Advisory position in Q2 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of Cape Investment Advisory's portfolio in Q2 2026, its #985 holding.
  • Cape Investment Advisory first reported a position in BeOne Medicines Ltd in Q2 2025 and has held it in 4 quarters since.
  • Cape Investment Advisory's BeOne Medicines Ltd position peaked at $6.13K in Q3 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.